AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15255620
Drug: Captopril and
RxNorm normalized name: captopril and diuretics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril and Losartan (A.C.E. inhibitors and A.II.R. antagonists)
Trial: 26510709
Drug: Bitter-tasting phenylalanine-free
RxNorm normalized name: BITTER MELON
DrugBank: Momordica charantia fruit (DB14265)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bitter-tasting phenylalanine-free l-amino acid exposure
Trial: 12538507
Drug: 4-hydroxyandrostenedione (aromatase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4-hydroxyandrostenedione (aromatase inhibitor)
Trial: 10800604
Drug: Artificial tear
RxNorm normalized name: Artificial Tears
DrugBank: Polyethylene glycol 400 (DB11077)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artificial tear ointment applied to one eye
Trial: 8645677
Drug: Fluconazole (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole (50 mg daily for 7 days)
Trial: 1524175
Drug: Oral clonidine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral clonidine, mean dose 3.6 micrograms/kg (n = 28)
Trial: 1524175
Drug: Oral diazepam,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral diazepam, 0.2 mg/kg (n = 30)
Trial: 26992129
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy plus Amitriptyline
Trial: 22476387
Drug: Warfarin 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin 25 mg (Day 1)
Trial: 1738570
Drug: s‐CT (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: s‐CT (200 IU infusion)
Trial: 6438935
Drug: Intracoronary infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary infusion of 0.2 mg nifedipine and 10 mg sublingual nifedipine (group I)
Trial: 6438935
Drug: Intracoronary infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary infusion of 0.4 mg 3‐N‐morpholinosyndnonimine (SIN‐1) (group II)
Trial: 20860912
Drug: Vildagliptin 50
RxNorm normalized name: vildagliptin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vildagliptin 50 mg twice daily
Trial: 23412170
Drug: Intra-articular PRP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular PRP injection
Trial: 16565035
Drug: Occupational therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational therapy as usual
Trial: 27883233
Drug: Intranasal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal insulin application
Trial: 23408502
Drug: Combination (ADF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination (ADF plus endurance exercise)
Trial: 2117857
Drug: Nitrofurans (conventional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrofurans (conventional therapy)
Trial: 17616788
Drug: 3000 mg
RxNorm normalized name: talc 3000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3000 mg calcium carbonate + 1400 IU cholecalciferol
Trial: 15056835
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (ACEI + ARB)
Trial: 15056835
Drug: Monotherapy (ACEI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy (ACEI or ARB)
Trial: 12599448
Drug: BCG polysaccharides
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG polysaccharides nucleic acid (BCG-PSN) 0.5 mg intramuscular injection, quaque die alterna, for 18 times
Trial: 31896036
Drug: Prior GIB
RxNorm normalized name: Priorix
DrugBank: Rubella virus vaccine (DB10317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prior GIB (both Apixaban and Warfarin)
Trial: 31896036
Drug: Prior GIB
RxNorm normalized name: Priorix
DrugBank: Rubella virus vaccine (DB10317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prior GIB <1 year before randomization (both Apixaban and Warfarin)
Trial: 23318051
Drug: Glibenclamide (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glibenclamide (single morning dose)
Trial: 21109365
Drug: Oral ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ketamine 150 mg
Trial: 17304396
Drug: Early-fed group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early-fed group (250 ml clear fruit juice 30 minutes postoperatively, unlimited solid food thereafter)
Trial: 15031571
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg nebivolol
Trial: 2439786
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg bisoprolol
Trial: 1378144
Drug: Carvedilol 25
RxNorm normalized name: carvedilol 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol 25 mg p.o.
Trial: 27214383
Drug: CoQ10 300
RxNorm normalized name: CoQ10
DrugBank: Ubidecarenone (DB09270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CoQ10 300 mg loading dose 12 hours before procedure
Trial: 24656645
Drug: Control (vehicle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (vehicle injection)
Trial: 22331951
Drug: Overall AI
RxNorm normalized name: AI-128
DrugBank: AI-128 (DB05841)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall AI therapy
Trial: 22331951
Drug: Younger age
RxNorm normalized name: AGS-499
DrugBank: AGS-499 (DB18058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Younger age and taxane-based chemotherapy
Trial: 20819882
Drug: Prednisone therapy
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisone therapy (treated group)
Trial: 1950033
Drug: Lovastatin 20
RxNorm normalized name: lovastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovastatin 20 mg
Trial: 2059002
Drug: Computer network
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computer network support for caregivers; details on dosage and duration not available.
Trial: 6650699
Drug: Tacrine (45-90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tacrine (45-90 mg/day)
Trial: 24661819
Drug: Taking more
RxNorm normalized name: polyurethane-35 (not more than MPA.S at 40 %)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taking more (7+) prescription medications
Trial: 18283734
Drug: Interferon tablets
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon tablets 4000 IU
Trial: 29061746
Drug: Dispersible-tablet formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dispersible-tablet formulation of dihydroartemisinin/piperaquine phosphate (DHA/PQP)
Trial: 29061746
Drug: Crushed tablets
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crushed tablets (Eurartesim)
Trial: 2113671
Drug: Haemophilus influenzae
RxNorm normalized name: HAEMOPHILUS INFLUENZAE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine (given at ages 1 and 3 months)
Trial: 2113671
Drug: Haemophilus influenzae
RxNorm normalized name: HAEMOPHILUS INFLUENZAE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine (given at ages 2 and 4 months)
Trial: 31484659
Drug: 9cUAB30 (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9cUAB30 (20 mg dose level)
Trial: 31484659
Drug: 9cUAB30 (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9cUAB30 (240 mg dose level)
Trial: 29250974
Drug: Moistened misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Moistened misoprostol (200 µl distilled water, 2 × 200 μg)
Trial: 29250974
Drug: Dry misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dry misoprostol (2 × 200 μg)
Trial: 22403981
Drug: Intra-oral hearing
RxNorm normalized name: carbamide peroxide
DrugBank: Carbamide peroxide (DB11129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intra-oral hearing device (SoundBite)
Trial: 11345378
Drug: Oral pharmacologic
RxNorm normalized name: COPD pharmacologic substance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral pharmacologic treatment with flecainide (group A, n = 23)
Trial: 11345378
Drug: Hybrid treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hybrid treatment (catheter ablation of the inferior vena cava‐tricuspid annulus isthmus, plus oral flecainide) (group B, n = 24)
Trial: 28844541
Drug: MEDI8852 (250,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MEDI8852 (250, 750, 1,500, or 3000 mg)
Trial: 23504050
Drug: 250 mcg
RxNorm normalized name: Nplate 250 MCG Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mcg IFNB‐1b
Trial: 21521860
Drug: Generic levetiracetam
RxNorm normalized name: Levetiracetam
DrugBank: Levetiracetam (DB01202)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Generic levetiracetam formulations
Trial: 19745646
Drug: Antipsychotics (neuroleptics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipsychotics (neuroleptics and atypicals)
Trial: 17928597
Drug: Doxorubicin (60,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin (60, 75, or 90 mg per square meter) plus cyclophosphamide (600 mg per square meter)
Trial: 11681650
Drug: PARI (3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PARI (3.0 mg nebulized until dry)
Trial: 9627590
Drug: Acellular vaccines
RxNorm normalized name: PERTUSSIS VACCINE,ACELLULAR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acellular vaccines (two three-component vaccines)
Trial: 9272346
Drug: Whole-cell vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-cell vaccine
Trial: 26771781
Drug: Thiamine 200
RxNorm normalized name: thiamine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiamine 200 mg twice daily for 7 days
Trial: 25015597
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution (n = 162)
Trial: 20466437
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg eicosapentaenoic acid (EPA)
Trial: 15764422
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg fluoxetine
Trial: 20466437
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg fluoxetine (control)
Trial: 11113686
Drug: Glibenclamide at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glibenclamide at 5 mg/day
Trial: 11113686
Drug: Voglibose at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Voglibose at 0.6 mg/day
Trial: 8669673
Drug: Spinal anesthesia
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal anesthesia with 0.5% bupivacaine (2-4 ml)
Trial: 8669673
Drug: Ice-cold lactated
RxNorm normalized name: acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ice-cold lactated Ringer's solution administered intravenously before spinal blockade
Trial: 31099474
Drug: Topical dorzolamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical dorzolamide 2% q8h
Trial: 31099474
Drug: Topical brinzolamide
RxNorm normalized name: Brinzolamide
DrugBank: Brinzolamide (DB01194)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topical brinzolamide 1% q8h
Trial: 31099474
Drug: Topical timolol
RxNorm normalized name: timolol
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topical timolol 0.5% q12h combined with dorzolamide
Trial: 31099474
Drug: Topical timolol
RxNorm normalized name: timolol
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topical timolol 0.5% q12h combined with brinzolamide
Trial: 23633187
Drug: Prophylactic antibiotics
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic antibiotics administered before skin incision
Trial: 23633187
Drug: Prophylactic antibiotics
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic antibiotics administered after obtaining operative cultures
Trial: 23108892
Drug: Cisplatin (CDDP)
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin (CDDP) 100 mg/m2 on day 1 plus Gemcitabine (Gem) 1,250 mg/m2 on days 1 and 8 every 3 weeks
Trial: 21960587
Drug: Alemtuzumab (annual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alemtuzumab (annual treatment)
Trial: 21960587
Drug: Surviving patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surviving patients post-ITP treatment
Trial: 18926826
Drug: Budesonide 6
RxNorm normalized name: budesonide 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 6 mg/d
Trial: 8835114
Drug: Intravenous cisplatinum
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous cisplatinum (CDP)
Trial: 3095410
Drug: Allergen solution
RxNorm normalized name: catfish allergenic extract
DrugBank: Diphenylpyraline (DB01146)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Allergen solution (freeze-dried allergen extract reconstituted with isotonic saline)
Trial: 3095410
Drug: Control solution
RxNorm normalized name: Nausea Control Solution
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control solution (isotonic saline, 0.9% w/v)
Trial: 3095410
Drug: Allergen solution
RxNorm normalized name: catfish allergenic extract
DrugBank: Diphenylpyraline (DB01146)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Allergen solution (freeze-dried allergen extract reconstituted with isotonic saline) in nonatopic control subjects
Trial: 3095410
Drug: Control solution
RxNorm normalized name: Nausea Control Solution
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control solution (isotonic saline, 0.9% w/v) in nonatopic control subjects
Trial: 18248643
Drug: Ghrelin injection
RxNorm normalized name: Ghrelin
DrugBank: Lenomorelin (DB11895)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ghrelin injection
Trial: 29506157
Drug: Oral glucose
RxNorm normalized name: glucose Oral Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral glucose tolerance test (OGTT)
Trial: 12610021
Drug: Inhaled insulin
RxNorm normalized name: insulin, regular, human Inhalation Powder [Afrezza]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled insulin (33.8 IU) administered to smokers
Trial: 10726229
Drug: Large doses
RxNorm normalized name: Largemouth bass
DrugBank: Largemouth bass (DB10976)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Large doses of polyethylene glycol
Trial: 15206496
Drug: Enalapril 10
RxNorm normalized name: enalapril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 10 mg/day
Trial: 7731143
Drug: Felodipine 5
RxNorm normalized name: felodipine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine 5 mg/day
Trial: 1664106
Drug: Hashish (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hashish (200 mg hashish with 11.5% THC per 1 g tobacco cigarette)
Trial: 26062192
Drug: Subgaleal acupoint
RxNorm normalized name: Bismuth subgallate
DrugBank: Bismuth subgallate (DB13909)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subgaleal acupoint injection with metoclopramide
Trial: 21555967
Drug: Intravitreal bevacizumab
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intravitreal bevacizumab (IVB) - 3 consecutive injections of 1.25 mg given 6 weeks apart.
Trial: 21555967
Drug: Combined intravitreal
RxNorm normalized name: Dexamethasone Intravitreal Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined intravitreal bevacizumab and triamcinolone (IVB/IVT) - first injection combined with 2 mg of triamcinolone.
Trial: 7979117
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose ketamine by subcutaneous infusion (0.1 mg.kg‐1.h‐1)
Trial: 7979117
Drug: Morphine by
RxNorm normalized name: By Ache
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine by subcutaneous infusion (0.03 mg.kg‐1.h‐1)
Trial: 27796647
Drug: Extended infusion
RxNorm normalized name: Extended Infusion Set 6mm Cannula 23" Tubing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended infusion (EI) of piperacillin/tazobactam (4/0.5 g over 3 hours every 6 hours)
Trial: 27796647
Drug: Intermittent infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intermittent infusion (II) of piperacillin/tazobactam (4/0.5 g over 30 minutes)
Trial: 21575503
Drug: CPT‐11 +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPT‐11 + CAP (irinotecan 100 mg/m² on days 1 and 8; capecitabine 2000 mg/m² bid for 14 days, repeated every 21 days)
Trial: 21575503
Drug: L‐OHP +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L‐OHP + CAP (oxaliplatin 100 mg/m² on day 1; capecitabine 2000 mg/m² bid for 14 days, repeated every 21 days)
Trial: 12626469
Drug: High carbohydrate
RxNorm normalized name: High carbohydrate food
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High carbohydrate availability (HC) - 9.32 +/- 0.08 g.kg(-1).day(-1)
Trial: 12626469
Drug: Low carbohydrate
RxNorm normalized name: Low carbohydrate beer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low carbohydrate availability (LC) - 0.59 +/- 0.21 g.kg(-1).day(-1)
Trial: 8403637
Drug: Ilizarov external
RxNorm normalized name: CATHETER,EXTERNAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ilizarov external fixator with gentamicin methylmethacrylate bead (GMB) and intravenous antibiotics (Group 2)
Trial: 8403637
Drug: Ilizarov external
RxNorm normalized name: CATHETER,EXTERNAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ilizarov external fixator with initial debridement and intravenous antibiotics (Group 1)
Trial: 21847569
Drug: LY2140023 monohydrate
RxNorm normalized name: Lactose Monohydrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LY2140023 monohydrate 40 mg orally twice daily for 14 days
Trial: 21847569
Drug: LY404039 (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LY404039 (single intraperitoneal injection)
Trial: 6352780
Drug: Albuterol (inhalations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol (inhalations from a metered dose inhaler) - 1, 2, 4, 6, and 8 inhalations
Trial: 6352780
Drug: Albuterol (delivered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol (delivered by IPPB) - 1.25, 2.5, 5, 10, and 15 mg
Trial: 30356287
Drug: Recent HIV
RxNorm normalized name: HIV Integrase Inhibitor
DrugBank: HIV Integrase Inhibitor (DB16114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recent HIV infections (ARV-naïve individuals with detectable HIV-1 RNA >400 copies/mL)
Trial: 27138295
Drug: Tramadol extended
RxNorm normalized name: tramadol Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol extended release (ER) 25 to 100 mg
Trial: 24506852
Drug: Modified surviving
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified surviving sepsis bundles group (n=42) with PiCCO catheter and fluid resuscitation guided by ITBVI (850-1000 mL/m²), dobutamine for heart function, norepinephrine for MAP maintenance, and monitoring of extra-vascular lung water.
Trial: 20236862
Drug: Human menopausal
RxNorm normalized name: Human menopausal gonadotropin
DrugBank: Chorionic Gonadotropin (Human) (DB09126)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human menopausal gonadotrophin or follicle‐stimulating hormone following the long gonadotrophin‐releasing hormone agonist protocol
Trial: 20236862
Drug: Best predictive
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Best predictive model using age, duration of infertility, infertility diagnosis, endometrial thickness, pre‐stimulation total testosterone and sex hormone‐binding globulin concentrations
Trial: 27007068
Drug: 60 mg/d
RxNorm normalized name: cabozantinib s-malate 60 mg/day (20 mg x 3/day) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg/d etoricoxib
Trial: 25081826
Drug: PAS 200
RxNorm normalized name: Urispas 200 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PAS 200 (200 mg PS & 200 mg PA per day)
Trial: 17973637
Drug: 5-HT(3) antagonist
RxNorm normalized name: 5-HT
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-HT(3) antagonist ondansetron given orally
Trial: 9447279
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist therapy for 6 months
Trial: 8941780
Drug: Ibuprofen effervescent
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen effervescent granules 600 mg (Brufen Granules)
Trial: 8645662
Drug: Ibuprofen tablets
RxNorm normalized name: Ibuprofen Tablets
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen tablets 600 mg
Trial: 676309
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral dose of 200,000 IU vitamin D3
Trial: 27096709
Drug: Clobetasol propionate
RxNorm normalized name: Clobetasol Propionate
DrugBank: Clobetasol propionate (DB01013)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Clobetasol propionate cream, 0.05% w/w